PEPTIDES CROSSING A BRAIN ENDOTHELIAL CELL LAYER
The present invention relates to antibody molecules and peptide delivery systems for use in the treatment and management of Alzheimer's disease and related disorders. In particular, the antibody molecules preferentially bind oligomeric forms of beta-amyloid peptide, in single domain format, and...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Rico Botas Castanho, Miguel Augusto Castanheira Aires da Silva, Frederico Nuno Fleming Outeiro, Tiago Volker Côrte-Real, Sofia Correia Canhão, Pedro Manuel Santos Neves, Vera Luísa |
| description | The present invention relates to antibody molecules and peptide delivery systems for use in the treatment and management of Alzheimer's disease and related disorders. In particular, the antibody molecules preferentially bind oligomeric forms of beta-amyloid peptide, in single domain format, and the peptide delivery systems facilitate specific transport of such antibody molecules, as well as other cargo molecules, across the blood-brain barrier. The invention also relates to constructs of the antibody molecules and the delivery peptides, as well as pharmaceutical compositions comprising effective amounts of the antibody molecules, delivery peptides, and/or their constructs, including humanized versions of the antibody molecules and constructs. The invention further relates to methods of making these products and pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions in treating or preventing Alzheimer's and related disorders, such as those involving accumulation of beta-amyloid peptide or other peptides that aggregate in the brain; as well as to methods and kits for diagnosing these disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4183795A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4183795A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4183795A13</originalsourceid><addsrcrecordid>eNrjZDAIcA0I8XRxDVZwDvIPDvb0c1dwVHAKcvT0U3D1c_EP8XD18XT0UXB29fFR8HGMdA3iYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmhhbG5pamjobGRCgBANJsJcI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PEPTIDES CROSSING A BRAIN ENDOTHELIAL CELL LAYER</title><source>esp@cenet</source><creator>Rico Botas Castanho, Miguel Augusto ; Castanheira Aires da Silva, Frederico Nuno ; Fleming Outeiro, Tiago ; Volker Côrte-Real, Sofia ; Correia Canhão, Pedro Manuel ; Santos Neves, Vera Luísa</creator><creatorcontrib>Rico Botas Castanho, Miguel Augusto ; Castanheira Aires da Silva, Frederico Nuno ; Fleming Outeiro, Tiago ; Volker Côrte-Real, Sofia ; Correia Canhão, Pedro Manuel ; Santos Neves, Vera Luísa</creatorcontrib><description>The present invention relates to antibody molecules and peptide delivery systems for use in the treatment and management of Alzheimer's disease and related disorders. In particular, the antibody molecules preferentially bind oligomeric forms of beta-amyloid peptide, in single domain format, and the peptide delivery systems facilitate specific transport of such antibody molecules, as well as other cargo molecules, across the blood-brain barrier. The invention also relates to constructs of the antibody molecules and the delivery peptides, as well as pharmaceutical compositions comprising effective amounts of the antibody molecules, delivery peptides, and/or their constructs, including humanized versions of the antibody molecules and constructs. The invention further relates to methods of making these products and pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions in treating or preventing Alzheimer's and related disorders, such as those involving accumulation of beta-amyloid peptide or other peptides that aggregate in the brain; as well as to methods and kits for diagnosing these disorders.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230524&DB=EPODOC&CC=EP&NR=4183795A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230524&DB=EPODOC&CC=EP&NR=4183795A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Rico Botas Castanho, Miguel Augusto</creatorcontrib><creatorcontrib>Castanheira Aires da Silva, Frederico Nuno</creatorcontrib><creatorcontrib>Fleming Outeiro, Tiago</creatorcontrib><creatorcontrib>Volker Côrte-Real, Sofia</creatorcontrib><creatorcontrib>Correia Canhão, Pedro Manuel</creatorcontrib><creatorcontrib>Santos Neves, Vera Luísa</creatorcontrib><title>PEPTIDES CROSSING A BRAIN ENDOTHELIAL CELL LAYER</title><description>The present invention relates to antibody molecules and peptide delivery systems for use in the treatment and management of Alzheimer's disease and related disorders. In particular, the antibody molecules preferentially bind oligomeric forms of beta-amyloid peptide, in single domain format, and the peptide delivery systems facilitate specific transport of such antibody molecules, as well as other cargo molecules, across the blood-brain barrier. The invention also relates to constructs of the antibody molecules and the delivery peptides, as well as pharmaceutical compositions comprising effective amounts of the antibody molecules, delivery peptides, and/or their constructs, including humanized versions of the antibody molecules and constructs. The invention further relates to methods of making these products and pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions in treating or preventing Alzheimer's and related disorders, such as those involving accumulation of beta-amyloid peptide or other peptides that aggregate in the brain; as well as to methods and kits for diagnosing these disorders.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAIcA0I8XRxDVZwDvIPDvb0c1dwVHAKcvT0U3D1c_EP8XD18XT0UXB29fFR8HGMdA3iYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmhhbG5pamjobGRCgBANJsJcI</recordid><startdate>20230524</startdate><enddate>20230524</enddate><creator>Rico Botas Castanho, Miguel Augusto</creator><creator>Castanheira Aires da Silva, Frederico Nuno</creator><creator>Fleming Outeiro, Tiago</creator><creator>Volker Côrte-Real, Sofia</creator><creator>Correia Canhão, Pedro Manuel</creator><creator>Santos Neves, Vera Luísa</creator><scope>EVB</scope></search><sort><creationdate>20230524</creationdate><title>PEPTIDES CROSSING A BRAIN ENDOTHELIAL CELL LAYER</title><author>Rico Botas Castanho, Miguel Augusto ; Castanheira Aires da Silva, Frederico Nuno ; Fleming Outeiro, Tiago ; Volker Côrte-Real, Sofia ; Correia Canhão, Pedro Manuel ; Santos Neves, Vera Luísa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4183795A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>Rico Botas Castanho, Miguel Augusto</creatorcontrib><creatorcontrib>Castanheira Aires da Silva, Frederico Nuno</creatorcontrib><creatorcontrib>Fleming Outeiro, Tiago</creatorcontrib><creatorcontrib>Volker Côrte-Real, Sofia</creatorcontrib><creatorcontrib>Correia Canhão, Pedro Manuel</creatorcontrib><creatorcontrib>Santos Neves, Vera Luísa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Rico Botas Castanho, Miguel Augusto</au><au>Castanheira Aires da Silva, Frederico Nuno</au><au>Fleming Outeiro, Tiago</au><au>Volker Côrte-Real, Sofia</au><au>Correia Canhão, Pedro Manuel</au><au>Santos Neves, Vera Luísa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PEPTIDES CROSSING A BRAIN ENDOTHELIAL CELL LAYER</title><date>2023-05-24</date><risdate>2023</risdate><abstract>The present invention relates to antibody molecules and peptide delivery systems for use in the treatment and management of Alzheimer's disease and related disorders. In particular, the antibody molecules preferentially bind oligomeric forms of beta-amyloid peptide, in single domain format, and the peptide delivery systems facilitate specific transport of such antibody molecules, as well as other cargo molecules, across the blood-brain barrier. The invention also relates to constructs of the antibody molecules and the delivery peptides, as well as pharmaceutical compositions comprising effective amounts of the antibody molecules, delivery peptides, and/or their constructs, including humanized versions of the antibody molecules and constructs. The invention further relates to methods of making these products and pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions in treating or preventing Alzheimer's and related disorders, such as those involving accumulation of beta-amyloid peptide or other peptides that aggregate in the brain; as well as to methods and kits for diagnosing these disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4183795A1 |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | PEPTIDES CROSSING A BRAIN ENDOTHELIAL CELL LAYER |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T08%3A04%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Rico%20Botas%20Castanho,%20Miguel%20Augusto&rft.date=2023-05-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4183795A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |